Search research articles
Contact Us
Filters
Showing results (101-110 of 185) with videos related to
Page
of 19
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
January 9, 2009
Management of high blood pressure in clinical practice: perceptible qualitative differences in approaches utilized by clinicians
Chuke E Nwachuku, Arnaud Bastien, Jeffrey A Cutler, et al.
Journal of the American College of Cardiology
|
February 7, 2018
Magnetic Resonance Imaging-Based Screening Study in a General Population of Adolescents
Paolo Angelini, Benjamin Y Cheong, Veronica V Lenge De Rosen, et al.
The Lancet. Oncology
|
April 1, 2021
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
Emma Copland, Dexter Canoy, Milad Nazarzadeh, et al.
Journal of Hypertension
|
June 26, 2010
Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study
Marguerite R Irvin, Amy I Lynch, Edmond K Kabagambe, et al.
Journal of the National Medical Association
|
August 22, 2018
Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT
L Julian Haywood, Barry R Davis, Linda B Piller, et al.
Journal of the National Medical Association
|
October 9, 2017
Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT
L Julian Haywood, Barry R Davis, Linda B Piller, et al.
Journal of Hypertension
|
May 21, 2014
Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT
Efrain Reisin, John W Graves, José-Miguel Yamal, et al.
JAMA Internal Medicine
|
July 2, 2016
Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease
Thomas A Dewland, Elsayed Z Soliman, Barry R Davis, et al.
American Heart Journal
|
December 19, 2006
Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study
Anke-Hilse Maitland-van der Zee, Eric Boerwinkle, Donna K Arnett, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
September 16, 2009
Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?
Richard H Grimm, Barry R Davis, Linda B Piller, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 185) with videos related to
Sort By:
Page
of 19
Journal of Clinical Hypertension (Greenwich, Conn.)
|
January 9, 2009
Management of high blood pressure in clinical practice: perceptible qualitative differences in approaches utilized by clinicians
Chuke E Nwachuku, Arnaud Bastien, Jeffrey A Cutler, et al.
Journal of the American College of Cardiology
|
February 7, 2018
Magnetic Resonance Imaging-Based Screening Study in a General Population of Adolescents
Paolo Angelini, Benjamin Y Cheong, Veronica V Lenge De Rosen, et al.
The Lancet. Oncology
|
April 1, 2021
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
Emma Copland, Dexter Canoy, Milad Nazarzadeh, et al.
Journal of Hypertension
|
June 26, 2010
Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study
Marguerite R Irvin, Amy I Lynch, Edmond K Kabagambe, et al.
Journal of the National Medical Association
|
August 22, 2018
Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT
L Julian Haywood, Barry R Davis, Linda B Piller, et al.
Journal of the National Medical Association
|
October 9, 2017
Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT
L Julian Haywood, Barry R Davis, Linda B Piller, et al.
Journal of Hypertension
|
May 21, 2014
Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT
Efrain Reisin, John W Graves, José-Miguel Yamal, et al.
JAMA Internal Medicine
|
July 2, 2016
Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on Conduction System Disease
Thomas A Dewland, Elsayed Z Soliman, Barry R Davis, et al.
American Heart Journal
|
December 19, 2006
Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study
Anke-Hilse Maitland-van der Zee, Eric Boerwinkle, Donna K Arnett, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
September 16, 2009
Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?
Richard H Grimm, Barry R Davis, Linda B Piller, et al.
Page
of 19